OptiMoM Kindergarten Study

January 11, 2019 updated by: Deborah O'Connor, The Hospital for Sick Children

Optimizing Mothers' Milk for Preterm Infants (OptiMoM) Program of Research: Study 1-Impact of Donor Milk at Kindergarten

In Canada, the leading cause of long-term disability in children is being born at very low birth weight (VLBW). To help improve outcomes, nutrition is a modifiable aspect of infant care. Mother's milk is the optimal way to feed VLBW infants; however, many need a supplement of donor milk or preterm formula as not enough mother's milk is available. As the ideal supplement for prolonged feeding and its long-term effects is currently unknown, this study is a prospective follow up of VLBW infants who in hospital were fed: donor milk or preterm formula and/or mother's milk. Areas of development to be assessed include: cognition, language, motor skills, brain structure/function, and body composition. A DNA biorepository will also be created.

Study Overview

Study Type

Observational

Enrollment (Actual)

158

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ontario
      • Toronto, Ontario, Canada, M5G 1X8
        • The Hospital for Sick Children

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

5 years to 6 years (Child)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Very low birth weight infants previously enrolled in the DoMINO (Donor Milk for Improved Neurodevelopmental Outcomes) trial (ISRCTN35317141).

Description

Inclusion Criteria:

  • Children who were enrolled in the DoMINO (Donor Milk for Improved Neurodevelopmental Outcomes) trial (ISRCTN35317141).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Children previously assigned to donor milk in the DoMINO trial
This study is an observational study of children who were enrolled in a previous trial (DoMINO trial) between 2010 and 2012 during which they were randomized to receive donor milk when mother's own breastmilk was unavailable. Donor milk was from a milk bank part of the Human Milk Banking Association of North America (HMBANA).
Children previously assigned to formula in the DoMINO trial
This study is an observational study of children who were enrolled in a previous trial (DoMINO trial) between 2010 and 2012 during which they were randomized to receive preterm formula when mother's own breastmilk was unavailable. Preterm formula was either Similac Special Care or Enfamil Premature depending on hospital contract with formula companies.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Full-Scale IQ on the Wechsler Preschool and Primary Scale of Intelligence-IV (WPPSI-IV)
Time Frame: 5.5 years of age
5.5 years of age

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Verbal IQ on the WPPSI-IV
Time Frame: 5.5 years of age
5.5 years of age
Performance IQ on the WPPSI-IV
Time Frame: 5.5 years of age
5.5 years of age
General Language Composite on the WPPSI-IV
Time Frame: 5.5 years of age
5.5 years of age
Processing Speed Quotient on the WPPSI-IV
Time Frame: 5.5 years of age
5.5 years of age
Growth
Time Frame: 5.5 years of age
Growth as assessed using weight, height and waist circumference measurements.
5.5 years of age
Body Composition
Time Frame: 5.5 years of age
Body composition as assessed using the COSMED BOD POD and skinfold thickness.
5.5 years of age

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Affect Recognition domain on the NEPSY-II
Time Frame: 5.5 years of age
5.5 years of age
Language domain on the NEPSY-II
Time Frame: 5.5 years of age
5.5 years of age
Memory domain on the NEPSY-II
Time Frame: 5.5 years of age
5.5 years of age
Visual-Motor Integration using the Beery
Time Frame: 5.5 years of age
5.5 years of age
Development of Brain Structure
Time Frame: 5.5 years of age
Development of brain structure as assessed using Magnetic Resonance Imaging (MRI).
5.5 years of age
Development of Brain Function
Time Frame: 5.5 years of age
Development of brain function as assessed using Magnetoencephalography (MEG).
5.5 years of age
Interaction of genetic differences and feeding type on outcomes
Time Frame: 5.5 years of age
Assessed using a buccal cell biorepository.
5.5 years of age
Influence of the diet on epigenetic changes
Time Frame: 5.5 years of age
Assessed using a buccal cell biorepository.
5.5 years of age
School Readiness using the Early Development Instrument (EDI)
Time Frame: 5.5 years of age
5.5 years of age

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2016

Primary Completion (Actual)

July 1, 2018

Study Completion (Actual)

July 1, 2018

Study Registration Dates

First Submitted

April 26, 2016

First Submitted That Met QC Criteria

April 28, 2016

First Posted (Estimate)

May 3, 2016

Study Record Updates

Last Update Posted (Actual)

January 14, 2019

Last Update Submitted That Met QC Criteria

January 11, 2019

Last Verified

January 1, 2019

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 1000053053

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Infant, Very Low Birth Weight

Clinical Trials on Pasteurized donor human breastmilk

3
Subscribe